Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS)

Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS)

Detalles Bibliográficos
Autores principales: Rudwaleit, M, Claudepierre, P, Wordsworth, P, Loza, E, Wong, R, Kron, M, Kary, S, Kupper, H
Formato: Journal article
Publicado: 2008

Ejemplares similares